Biotricity, Inc. (NASDAQ:BTCY) Short Interest Up 30.8% in April

Biotricity, Inc. (NASDAQ:BTCYGet Free Report) was the target of a large increase in short interest in April. As of April 30th, there was short interest totalling 579,900 shares, an increase of 30.8% from the April 15th total of 443,400 shares. Approximately 7.4% of the shares of the stock are sold short. Based on an average daily volume of 107,600 shares, the days-to-cover ratio is presently 5.4 days.

Hedge Funds Weigh In On Biotricity

An institutional investor recently bought a new position in Biotricity stock. Advisor Resource Council acquired a new stake in Biotricity, Inc. (NASDAQ:BTCYFree Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 79,070 shares of the company’s stock, valued at approximately $117,000. Advisor Resource Council owned 0.84% of Biotricity at the end of the most recent quarter. 3.89% of the stock is owned by institutional investors and hedge funds.

Biotricity Stock Performance

Shares of BTCY traded up $0.02 during mid-day trading on Wednesday, hitting $1.14. 14,669 shares of the stock were exchanged, compared to its average volume of 80,573. The firm has a 50-day moving average of $1.31 and a two-hundred day moving average of $1.10. The company has a market cap of $10.74 million, a PE ratio of -0.82 and a beta of 1.54. Biotricity has a 52-week low of $0.70 and a 52-week high of $4.37.

Biotricity (NASDAQ:BTCYGet Free Report) last announced its earnings results on Tuesday, February 20th. The company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.07. The firm had revenue of $2.97 million during the quarter, compared to analyst estimates of $3.00 million. On average, sell-side analysts predict that Biotricity will post -1.55 EPS for the current year.

About Biotricity

(Get Free Report)

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

Featured Articles

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with's FREE daily email newsletter.